Clinical Trial Update: A Study Evaluating Treatment Regimens Containing Vebicorvir (ABI-H0731) in Participants With Chronic Hepatitis B Infection [Phase 2]

View source ↗

Summary

Phase 2 trial investigating regimens containing Vebicorvir (ABI-H0731) in chronic hepatitis B; the study status is terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Vebicorvir (ABI-H0731)

Snippet

Sponsor: Assembly Biosciences | Conditions: Chronic Hepatitis B | Phase 2 | Status: TERMINATED | Results posted: 2023-11-14